MAPT and Alzheimer disease: Increased levels of Aβ42/Aβ40 ratio, APP, Aβ monomer and oligomer forms, tau and tau phosphorylation were reported in EVs isolated from the plasma, CSF, and brain cells of AD patients and mouse models [202, 205, 206].